Patrys Limited (Patrys) is an Australia-based company. The principal activity of the Company is to develop natural human antibody based therapeutic products for the treatment of cancer and other diseases. The Company operates in two business segments: commercialization and investment in research and development companies. It primarily operates in three geographical areas, being Australia, Germany and the United States. Its wholly-owned subsidiary is Patrys GmbH. On November 28, 2008, Patrys acquired Acceptys, Inc.
Research Alerts:
Receive alerts on the latest reports on Patrys Limited
Subscribe to Research Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
